NxStage to Present at the Canaccord Adams Diabetes & Obesity Conference

Thursday April 30, 2009

LAWRENCE, Mass., April 30 /PRNewswire-FirstCall/ — NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced that Jeffrey H. Burbank, Chief Executive Officer, will be presenting at the Canaccord Adams Diabetes & Obesity Conference on Tuesday, May 12, 2009 at the InterContinental Barclay Hotel in New York.

NxStage’s investor presentation is scheduled for Tuesday, May 12th at 1:40 p.m. To listen to the audio webcast of the presentation during the event, please visit: http://www.nxstage.com and click on ‘Investor Information’.

About NxStage Medical

NxStage Medical, Inc. (Nasdaq: NXTM) is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative products for the treatment of end-stage renal disease, or ESRD, and acute kidney failure. For more information on NxStage and its products, please visit the company’s website at http://www.nxstage.com.

Forward-Looking Statements

This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this release that are not clearly historical in nature are forward-looking, and the words anticipate, believe, expect, estimate, plan, and similar expressions are generally intended to identify forward-looking statements. Examples of these forward-looking statements include statements as to Mr. Burbank’s plans to present at this conference. NxStage specifically disclaims any obligation to update these forward-looking statements. These forward-looking statements should not be relied upon as representing NxStage’s expectations or beliefs as of any date subsequent to the date of this press release.

CONTACT:
Kristen K. Sheppard, Esq.
Investor Relations
of NxStage Medical, Inc.
+1-978-332-5923
ksheppard@nxstage.com
Web Site: http://www.nxstage.com

SOURCE NxStage Medical, Inc.